[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
[ Tue, Nov 29th 2022 ]: WOPRAI
Maury Raycroft Maintained (ARWR) at Strong Buy with Decreased Target to $75 on, Nov 29th, 2022
- 🞛 This publication is a summary or evaluation of another publication
- 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Maury Raycroft of Jefferies, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Decreased Target from $92 to $75 on, Nov 29th, 2022.
Maury has made no other calls on ARWR in the last 4 months.
There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 0 agree with Maury's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Maury
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $64 on, Thursday, November 10th, 2022
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $65 on, Monday, August 8th, 2022